Experience of treating neuropsychiatric disorders with andaxine, tofranil and centredrine

Cover Page

Cite item

Full Text

Abstract

In the last decade, a large number of new drugs have been introduced for the treatment of neuropsychiatric disorders, which has raised high expectations among doctors. Thus, the first reports on the use of phenothiazine drugs in psychiatric practice were encouraging. Not only the recently ill, but many patients, who had been incarcerated in psychiatric hospitals for years or decades and were considered "defective", that is, had irreversible mental changes, were in remission and discharged from hospitals after the use of neuroleptics. This gave rise to talk of a "new era in the treatment of mental illness".

About the authors

D. M. Mendelevich

Kazan City Psychoneurological Dispensary of the Kazan Medical Institute

Author for correspondence.
Email: info@eco-vector.com
Russian Federation

References


© 2021 Mendelevich D.M.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies